Conflict of interest: The University of California, Regents receive funding for Dr. Saver's services as a scientific consultant regarding trial design and conduct to Covidien/ev3, BrainsGate, CoAxia, Grifols/Talecris, Ferrer, Mitsubishi, Genervon, Benechill, Asubio, and Sygnis. Dr. Saver is an investigator in the NIH FAST-MAG, MR RESCUE, ICES, CUFFS, CLEAR-ER and IMS 3 multicenter clinical trials for which the UC Regents receive payments based clinical trial performance; has served as an unpaid site investigator in a multicenter trials run by Covidien/ev3, Genervon, Lundbeck, and Mitsubishi for which the UC Regents received payments based on the clinical trial contracts for the number of subjects enrolled; and is an employee of the University of California, which holds a patent on retriever devices for stroke. The University of California, Regents receive funding for Dr. Jahan's services as a scientific consultant regarding trial design and conduct to Covidien/ev3 and Chestnut Medical, and is an employee of the University of California, which holds a patent on retriever devices for stroke. Dr. Levy serves as a scientific consultant for Covidien/ev3, Codman & Shurtleff, Inc, and TheraSyn Sensors, Inc; and receives fees for carotid stent training from Covidien/ev3 and Abbott Vascular. and ev3/Covidien Vascular Therapies. Dr. Jovin has served as a scientific consultant to Covidien/ev3, CoAxia, Concentric Medical, and Micrus. Dr. Nogueira has served as a scientific consultant to Covidien/ev3, CoAxia, and Concentric Medical. Dr. Clark and Dr. Budzik have served as scientific consultants to Covidien/ev3. Dr. Zaidat serves as a scientific consultant to Talecris Biotherapeutics, Stryker, Codman, and MicroVention.
SOLITAIRE™ with the intention for thrombectomy (SWIFT) trial: design of a randomized, controlled, multicenter study comparing the SOLITAIRE™ Flow Restoration device and the MERCI Retriever in acute ischaemic stroke
Article first published online: 6 NOV 2012
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization
International Journal of Stroke
Volume 9, Issue 5, pages 658–668, July 2014
How to Cite
Saver, J. L., Jahan, R., Levy, E. I., Jovin, T. G., Baxter, B., Nogueira, R., Clark, W., Budzik, R., Zaidat, O. O. and the SWIFT Trialists (2014), SOLITAIRE™ with the intention for thrombectomy (SWIFT) trial: design of a randomized, controlled, multicenter study comparing the SOLITAIRE™ Flow Restoration device and the MERCI Retriever in acute ischaemic stroke. International Journal of Stroke, 9: 658–668. doi: 10.1111/j.1747-4949.2012.00856.x
- Issue published online: 9 JUN 2014
- Article first published online: 6 NOV 2012
- Manuscript Accepted: 2 FEB 2012
- Manuscript Received: 9 OCT 2011
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.